Co-Diagnostics, Inc.(CODX)

Description: Co-Diagnostics, Inc. is a molecular diagnostics company. The Company is engaged in developing, manufacturing and marketing diagnostics technology. Its reagents are used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules, such as deoxyribonucleic acid and ribonucleic acid. It also sells diagnostic equipment from other manufacturers as self-contained lab systems (MDx device). The Company uses its proprietary test design system and proprietary reagents to design and sell polymerase chain reaction diagnostic tests for diseases and pathogens starting with tests for tuberculosis, a drug resistant tuberculosis test, hepatitis B and C, Malaria, dengue, human immunodeficiency virus and Zika virus, all of which tests have been designed and validated in its laboratory. Its diagnostics systems enable molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests.

---

Keywords: Medicine Biotechnology Clinical Medicine Disease Acid Organisms Medical Test Hepatitis B Diagnostic Tests Molecular Diagnostics Tuberculosis Polymerase Chain Reaction Genetic Diseases Immunodeficiency Malaria Diagnostic Equipment Ortho Clinical Diagnostics Dengue Dengue Fever Zika Mdx

---

Home Page: www.codiagnostics.com

CODX Technical Analysis

2401 South Foothill Drive
Salt Lake City, UT 84109
United States
Phone: 801 438 1036

---

Officers

Exchange: NASDAQ

Country: US

Currency: US Dollar ($)